A Top Financial Company’s Latest Healthcare Stock Favs

Following is information regarding Northern Trust Corporation’s top holdings in the Healthcare sector for the week ending September 30th, 2011.

  • Procter & Gamble Co. (NYSE:PG): On 6/30/11 Northern Trust Corporation reported holding 79,477,362 shares with a market value of $5,052,375,878. This comprised 1.84% of the total portfolio. On 9/30/11, Northern Trust Corporation held 40,101,097 shares with a market value of $2,533,587,321. This comprised 1.45% of the total portfolio. The net change in shares for this position over the two quarters is -39,376,265. About the company: The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Proctor & Gamble’s products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.
  • Johnson & Johnson (NYSE:JNJ): On 6/30/11 Northern Trust Corporation reported holding 35,631,694 shares with a market value of $2,370,220,165. This comprised 0.86% of the total portfolio. On 9/30/11, Northern Trust Corporation held 36,633,995 shares with a market value of $2,333,219,091. This comprised 1.33% of the total portfolio. The net change in shares for this position over the two quarters is 1,002,301. About the company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
  • Pfizer, Inc. (NYSE:PFE): On 6/30/11 Northern Trust Corporation reported holding 189,406,332 shares with a market value of $3,901,770,511. This comprised 1.42% of the total portfolio. On 9/30/11, Northern Trust Corporation held 97,269,886 shares with a market value of $1,719,731,614. This comprised 0.98% of the total portfolio. The net change in shares for this position over the two quarters is -92,136,446. About the company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
  • Abbott Laboratories, Inc. (NYSE:ABT): On 6/30/11 Northern Trust Corporation reported holding 23,728,650 shares with a market value of $1,248,601,538. This comprised 0.45% of the total portfolio. On 9/30/11, Northern Trust Corporation held 24,742,360 shares with a market value of $1,265,324,275. This comprised 0.72% of the total portfolio. The net change in shares for this position over the two quarters is 1,013,710. About the company: Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company’s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
  • Merck & Co., Inc. (NYSE:MRK): On 6/30/11 Northern Trust Corporation reported holding 71,847,866 shares with a market value of $2,535,511,257. This comprised 0.92% of the total portfolio. On 9/30/11, Northern Trust Corporation held 36,828,612 shares with a market value of $1,204,295,640. This comprised 0.69% of the total portfolio. The net change in shares for this position over the two quarters is -35,019,254. About the company: Merck & Co., Inc. is a global pharmaceutical company that discovers, develops, manufactures, and markets a broad range of human and animal health products. Merck’s products include a treatment for elevated cholesterol, a treatment for male pattern hair loss, a preventive treatment for osteoporosis, a treatment for hypertension, and a treatment for allergic rhinitis.
  • Bristol-Myers Squibb Company (NYSE:BMY): On 6/30/11 Northern Trust Corporation reported holding 21,954,660 shares with a market value of $635,806,933. This comprised 0.23% of the total portfolio. On 9/30/11, Northern Trust Corporation held 25,611,265 shares with a market value of $803,681,474. This comprised 0.46% of the total portfolio. The net change in shares for this position over the two quarters is 3,656,605. About the company: Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, manufactures and sells pharmaceutical and nutritional products. The Company’s products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders.
  • Amgen, Inc. (NASDAQ:AMGN): On 6/30/11 Northern Trust Corporation reported holding 10,447,923 shares with a market value of $609,636,291. This comprised 0.22% of the total portfolio. On 9/30/11, Northern Trust Corporation held 10,740,183 shares with a market value of $590,280,448. This comprised 0.34% of the total portfolio. The net change in shares for this position over the two quarters is 292,260. About the company: Amgen Inc. discovers, develops, manufactures, and markets human therapeutics based on cellular and molecular biology. The Company focuses its research on secreted protein and small molecule therapeutics, with particular emphasis on neuroscience and cancer. Amgen concentrates on the areas of hematology, cancer, infectious disease, endocrinology, neurobiology, and inflammation.
  • Eli Lilly & Co. (NYSE:LLY): On 6/30/11 Northern Trust Corporation reported holding 12,738,604 shares with a market value of $478,079,793. This comprised 0.17% of the total portfolio. On 9/30/11, Northern Trust Corporation held 13,044,379 shares with a market value of $482,250,708. This comprised 0.28% of the total portfolio. The net change in shares for this position over the two quarters is 305,775. About the company: Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. The Company’s products are sold in countries around the world. Eli Lilly’s products include neuroscience products, endocrine products, anti-infectives, cardiovascular agents, oncology products, and animal health products.
  • Medtronic, Inc. (NYSE:MDT): On 6/30/11 Northern Trust Corporation reported holding 26,855,166 shares with a market value of $1,034,729,513. This comprised 0.38% of the total portfolio. On 9/30/11, Northern Trust Corporation held 13,590,399 shares with a market value of $451,744,886. This comprised 0.26% of the total portfolio. The net change in shares for this position over the two quarters is -13,264,767. About the company: Medtronic, Inc. develops therapeutic and diagnostic medical products. The Company’s principal products include those for bradycardia pacing, tachyarrhythmia management, atrial fibrillation management, heart failure management, heart valve replacement, malignant and non-malignant pain, and movement disorders. Medtronic’s products are sold worldwide.
  • Baxter International, Inc. (NYSE:BAX): On 6/30/11 Northern Trust Corporation reported holding 7,683,202 shares with a market value of $458,610,317. This comprised 0.17% of the total portfolio. On 9/30/11, Northern Trust Corporation held 7,695,186 shares with a market value of $432,007,737. This comprised 0.25% of the total portfolio. The net change in shares for this position over the two quarters is 11,984. About the company: Baxter International Inc. develops, manufactures, and markets products and technologies related to hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. The Company’s products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices, and research laboratories.

(Note: Data regarding Northern Trust’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>